Act Capital Management, LLC Oncternal Therapeutics, Inc. Transaction History

Act Capital Management, LLC

$72.5 Million
Q3 2022

A detailed history of Act Capital Management, LLC transactions in Oncternal Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 210,000 shares of ONCT stock, worth $262,500. This represents 0.26% of its overall portfolio holdings.

Number of Shares

210,000

Previous 210,000 -0.0%

Holding current value

$262,500

Previous $233,000 19.74%

% of portfolio

0.26%

Previous 0.33%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.56 $10,500 - $23,400	-15,000 Reduced 6.67%	210,000 $233,000
Q1 2022 May 11, 2022	SELL	$1.37 - $2.43 $184,950 - $328,050	-135,000 Reduced 37.5%	225,000 $313,000
Q2 2021 Aug 16, 2021	BUY	$4.75 - $9.39 $1.71 Million - $3.38 Million	360,000 New	360,000 $1.71 Million

Others Institutions Holding ONCT

# of Institutions

Shares Held

362K

Call Options Held

Put Options Held

View Full List

About Oncternal Therapeutics, Inc.

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $69.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

More about ONCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Account

Act Capital Management, LLC Oncternal Therapeutics, Inc. Transaction History